Apelin-13 trifluoroacetate salt
SIGMA/A6469 - ≥95%
Synonym: Prepro-65-77-Apelin
Empirical Formula (Hill Notation): C69H111N23O16S · C2F3O2
Molecular Weight: 1663.84
Linear Formula: C69H111N23O16S · C2F3O2
Product Type: Chemical
assay | ≥95% |
form | powder |
InChI | 1S/C69H111N23O16S.C2HF3O2 |
InChI key | IUOVYCLNUOUEHV-PDGAQFIRSA |
Quality Level | 200 |
SMILES string | OC(=O)C(F)(F)F.CSCC[C@H]( |
storage temp. | −20°C |
UniProt accession no. | Q9ULZ1 |
Amino Acid Sequence: | Gln-Arg-Pro-Arg-Leu-Ser-H |
Application: | Apelin-13 trifluoroacetate salt has been used to determine whether apelin promotes progression of diabetic nephropathy (DN) by inducing podocyte dysfunction. It has also been used to examine the effects of apelin on myocardial infarction (MI) injury and underlying mechanisms. |
Biochem/physiol Actions: | Apelin plays physiological roles in the cytoprotection of many internal organs. It is used to treat insulin resistance and hypertension, but it may also can act as a negative factor. Apelin also regulates cardiovascular diseases. |
Biochem/physiol Actions: | Synthetic endogenous peptide agonist for the human APJ receptor, a putative receptor protein related to the angiotensin receptor (AT1). This peptide exerted an acidification-rate-promot |
General description: | Apelin is a regulatory peptide and a ligand of the APJ receptor. It is a member of the G protein-coupled receptor family. Apelin and APJ are broadly dispersed in the body. |
Other Notes: | Lyophilized from 0.1% TFA in H2O |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥95% |
Storage Temp. | −20°C |
UNSPSC | 12352202 |